HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ling Peng Selected Research

triethanolamine

3/2012Efficient delivery of sticky siRNA and potent gene silencing in a prostate cancer model using a generation 5 triethanolamine-core PAMAM dendrimer.
8/2009PAMAM dendrimers mediate siRNA delivery to target Hsp27 and produce potent antiproliferative effects on prostate cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ling Peng Research Topics

Disease

58Neoplasms (Cancer)
06/2022 - 10/2009
20Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2022 - 07/2010
12COVID-19
05/2022 - 01/2020
10Lung Neoplasms (Lung Cancer)
02/2022 - 01/2014
8Pancreatic Neoplasms (Pancreatic Cancer)
01/2019 - 02/2009
7Neoplasm Metastasis (Metastasis)
10/2022 - 03/2010
7Infections
07/2022 - 01/2005
7Hepatocellular Carcinoma (Hepatoma)
01/2022 - 11/2019
7Prostatic Neoplasms (Prostate Cancer)
01/2016 - 08/2009
6Fibrosis (Cirrhosis)
08/2022 - 01/2019
5Breast Neoplasms (Breast Cancer)
01/2021 - 03/2010
4Carcinogenesis
10/2022 - 10/2012
4Pneumonia (Pneumonitis)
02/2022 - 01/2020
4Adenocarcinoma
10/2021 - 01/2014
4Hypertension (High Blood Pressure)
10/2020 - 01/2016
3Carcinoma (Carcinomatosis)
04/2022 - 01/2014
3Lung Injury
01/2022 - 01/2020
3Brain Neoplasms (Brain Tumor)
01/2022 - 06/2020
3Inflammation (Inflammations)
01/2022 - 10/2020
3Disease Progression
10/2021 - 07/2020
3Neutropenia
10/2021 - 01/2019
3Hand-Foot Syndrome
01/2021 - 11/2013
3Chronic Obstructive Pulmonary Disease (COPD)
01/2020 - 07/2019
3Ovarian Neoplasms (Ovarian Cancer)
01/2018 - 12/2013
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2022 - 01/2021
2Respiratory Insufficiency (Respiratory Failure)
07/2022 - 10/2021
2Kidney Neoplasms (Kidney Cancer)
06/2022 - 01/2020
2Cystitis
04/2022 - 01/2021
2Liver Cirrhosis (Hepatic Cirrhosis)
10/2021 - 01/2014
2Pulmonary Fibrosis (Fibrosing Alveolitis)
06/2021 - 11/2020
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021 - 10/2017
2Hypoxia (Hypoxemia)
01/2021 - 01/2019
2Body Weight (Weight, Body)
11/2020 - 03/2020
2Insulin Resistance
11/2020 - 03/2020
2Critical Illness (Critically Ill)
07/2020 - 01/2020
2Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 01/2013
2Ureteral Obstruction
01/2019 - 06/2015
2Starvation
12/2018 - 07/2005

Drug/Important Bio-Agent (IBA)

22Pharmaceutical PreparationsIBA
05/2022 - 10/2009
17Proteins (Proteins, Gene)FDA Link
10/2022 - 10/2012
14Immune Checkpoint InhibitorsIBA
06/2022 - 01/2020
14Dendrimers (Dendrons)IBA
01/2022 - 08/2009
10RNA (Ribonucleic Acid)IBA
05/2022 - 01/2014
10Small Interfering RNA (siRNA)IBA
02/2022 - 08/2009
10Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2016
7Tyrosine Kinase InhibitorsIBA
10/2022 - 01/2017
7ErbB Receptors (EGF Receptor)IBA
01/2022 - 01/2014
5AlbuminsIBA
08/2022 - 01/2014
5Antiviral Agents (Antivirals)IBA
01/2022 - 02/2009
5Intrinsically Disordered ProteinsIBA
10/2021 - 01/2019
5NUPR1 inhibitor ZZW-115IBA
01/2021 - 01/2019
4LipidsIBA
02/2022 - 08/2012
4NucleosidesIBA
01/2015 - 12/2010
4HSP27 Heat-Shock ProteinsIBA
08/2012 - 08/2009
3Paclitaxel (Taxol)FDA LinkGeneric
04/2022 - 03/2014
3Angiotensin IIIBA
01/2022 - 01/2020
3Bevacizumab (Avastin)FDA Link
01/2022 - 01/2014
3Glucose (Dextrose)FDA LinkGeneric
01/2022 - 11/2018
3Therapeutic UsesIBA
01/2022 - 06/2020
3Biological ProductsIBA
10/2021 - 01/2019
3Inosine Diphosphate (IDP)IBA
10/2021 - 01/2019
3EnzymesIBA
06/2021 - 01/2013
3Transforming Growth Factors (Transforming Growth Factor)IBA
01/2021 - 06/2015
3Long Noncoding RNAIBA
01/2021 - 01/2019
3Messenger RNA (mRNA)IBA
01/2021 - 01/2014
3Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2020 - 01/2012
3MicroRNAs (MicroRNA)IBA
01/2016 - 01/2012
3TriazolesIBA
01/2015 - 10/2009
3GemcitabineFDA Link
12/2010 - 04/2010
2CreatinineIBA
08/2022 - 08/2016
2Rituximab (Mabthera)FDA Link
07/2022 - 10/2021
2LipopolysaccharidesIBA
06/2022 - 11/2020
2AntigensIBA
01/2022 - 01/2021
2Interleukin-10 (Interleukin 10)IBA
01/2022 - 06/2020
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 01/2021
2Circular RNAIBA
01/2022 - 01/2021
2Anaplastic Lymphoma KinaseIBA
01/2022 - 01/2021
2AntioxidantsIBA
10/2021 - 06/2021
2Metformin (Glucophage)FDA LinkGeneric
09/2021 - 11/2019
2GoldIBA
09/2021 - 11/2018
2CateninsIBA
03/2021 - 09/2018
2B7-H1 AntigenIBA
01/2021 - 01/2021
2LigandsIBA
01/2021 - 01/2021
2NivolumabIBA
01/2021 - 01/2020
2InterferonsIBA
10/2020 - 11/2019
2CytokinesIBA
07/2020 - 06/2020
2Nucleic AcidsIBA
04/2020 - 01/2020
2OligonucleotidesIBA
03/2020 - 01/2014
2lobaplatinIBA
11/2019 - 01/2014
2SmokeIBA
11/2019 - 07/2019
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019 - 01/2019
2Caspase 3 (Caspase-3)IBA
01/2019 - 09/2018
2NitrogenIBA
12/2018 - 07/2005
2Peptides (Polypeptides)IBA
11/2018 - 11/2014

Therapy/Procedure

30Therapeutics
06/2022 - 03/2010
11Immunotherapy
06/2022 - 01/2020
9Drug Therapy (Chemotherapy)
07/2022 - 05/2012
5Radiotherapy
10/2022 - 06/2020
2Molecular Targeted Therapy
06/2022 - 01/2014
2Precision Medicine
01/2019 - 11/2018